Exploring the role of angiogenesis in fibrosis and malignant transformation in oral submucous fibrosis: a systematic review and meta-analysis

키워드

참고문헌 (48)

1. Rajendran R, "Oral submucous fibrosis : etiology, pathogenesis, and future research", Bull World Health Organ, 72, pp.985~996 (1994)
2. Ekanayaka RP, "Oral submucous fibrosis : review on mechanisms of malignant transformation", Oral Surg Oral Med Oral Pathol Oral Radiol, 122, pp.192~199 (2016)[DOI]
3. Pindborg JJ, "Oral submucous fibrosis", Oral Surg Oral Med Oral Pathol, 22, pp.764~779 (1966)[DOI]
4. Tilakaratne WM, "Oral submucous fibrosis : review on aetiology and pathogenesis", Oral Oncol, 42, pp.561~568 (2006)[DOI]
5. More CB, "Classification system for oral submucous fibrosis", J Indian Acad Oral Med Radiol, 24, pp.24~29 (2012)[DOI]
6. Haider SM, "Clinical and functional staging of oral submucous fibrosis", Br J Oral Maxillofac Surg, 38, pp.12~15 (2000)[DOI]
7. Arakeri G, "Oral submucous fibrosis : an update on current theories of pathogenesis", J Oral Pathol Med, 46, pp.406~412 (2017)[DOI]
8. Ray JG, "Malignant transformation of oral submucous fibrosis : overview of histopathological aspects", Oral Surg Oral Med Oral Pathol Oral Radiol, 122, pp.200~209 (2016)[DOI]
9. Pandiar D, "Immunohistochemical expression of CD34 and basic fibroblast growth factor(bFGF)in oral submucous fibrosis", J Oral Maxillofac Pathol, 18, pp.155~161 (2014)[DOI]
10. Thakkannavar SS, "Histochemical and immunohistochemical analysis of collagen fibers and microvascular density in various grades of oral submucous fibrosis", Iran J Pathol, 14, pp.127~134 (2019)[DOI]
11. Tekade SA, "Early stage oral submucous fibrosis is characterized by increased vascularity as opposed to advanced stages", J Clin Diagn Res, pp.ZC92~ZC96 (2017)[DOI]
12. Madhavan Nirmal R, "Evaluation of micro-vessel density(Mvd)and vascular endothelial growth factor(Vegf)as possible indicator of malignant transformation in oral submucous fibrosis", J Dent Med Sci, 15, pp.72~77 (2016)
13. Rajendran R, "Characterisation and quantification of mucosal vasculature in oral submucous fibrosis", Indian J Dent Res, 16, pp.83~91 (2005)
14. Garg N, "Morphometric analysis of epithelial thickness and blood vessels in different grades of oral submucous fibrosis", Malays J Pathol, 36, pp.189~193 (2014)
15. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", PLoS Med, 6, pp.e1000097~ (2009)[DOI]
16. Singh M, "Morphometric analysis in potentially malignant head and neck lesions : oral submucous fibrosis", Asian Pac J Cancer Prev, 11, pp.257~260 (2010)
17. Sarode SC, "Conspicuous and frank dilated vascular spaces : a marker of malignant transformation in oral submucous fibrosis", J Oral Biol Craniofac Res, 11, pp.365~367 (2021)[DOI]
18. Pal M, "Malignant potentiality assessment of oral submucous fibrosis through semi-quantitative approach", J Oral Maxillofac Pathol, 24, pp.188~ (2020)[DOI]
19. Debnath S, "Morphometric analysis of oral submucous fibrosis and its correlation with histological staging and clinical severity of trismus", Egypt J Ear Nose Throat Allied Sci, 14, pp.85~90 (2013)[DOI]
20. Kapoor R, "Epithelial atrophy, fibrosis and vascularity correlation with epithelial dysplasia in oral submucous fibrosis, a prospective study", J Microsc Ultrastruct, 10, pp.1~6 (2020)[DOI]
21. Murgod VV, "Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma", J Oral Sci, 56, pp.173~178 (2014)[DOI]
22. Sirsat SM, "The vascular response in early and advanced oral submucous fibrosis", Acta Pathol Microbiol Scand, 70, pp.179~184 (1967)[DOI]
23. Gupta S, "The immunolocalization of mast cells in the pathology of oral submucous fibrosis", Cureus, 15, pp.e40069~ (2023)[DOI]
24. Hande AH, "Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity", J Cancer Res Ther, 18, pp.33~41 (2022)[DOI]
25. Gadbail AR, "Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis", J Investig Clin Dent, 10, pp.e12443~ (2019)[DOI]
26. Gadbail AR, "Ki67, CD105, and α-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization", J Oral Pathol Med, 46, pp.921~927 (2017)[DOI]
27. Gadbail AR, "Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis", PLoS One, 13, pp.e0200171~ (2018)[DOI]
28. Gadbail AR, "Ki67, CD105, and α-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis", Asian Pac J Cancer Prev, 21, pp.2067~2074 (2020)[DOI]
29. Gupta S, "Potentiated action on the progression of OSMF by hypoxia mediated signaling pathway by the epithelial mesenchymal transition and angiogenic apparatus", J Cancer Res Ther, 19(Suppl 1), pp.S389~S396 (2023)[DOI]
30. Sheelam S, "Role of cell proliferation and vascularity in malignant transformation of potentially malignant disorders", J Oral Maxillofac Pathol, 22, pp.281~ (2018)[DOI]
31. Anura A, "Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis", Pathol Res Pract, 210, pp.1054~1063 (2014)[DOI]
32. Anura A, "Computer-aided molecular pathology interpretation in exploring prospective markers for oral submucous fibrosis progression", Head Neck, 38, pp.653~669 (2016)[DOI]
33. Lin Y, "Expression and correlation of the Pi3k", Akt pathway and VEGF in oral submucous fibrosis, 2023, pp.56, e13491~
34. Das RK, "Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression", J Clin Pathol, 63, pp.894~899 (2010)[DOI]
35. Bavle RM, "Predicting the malignant transformation of oral submucous fibrosis using quantitative biomarkers p63 and CD31", J Orofac Sci, 12, pp.52~60 (2020)[DOI]
36. Khanna JN, "Oral submucous fibrosis : a new concept in surgical management. Report of 100 cases", Int J Oral Maxillofac Surg, 24, pp.433~439 (1995)[DOI]
37. Nayak S, "Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas", Indian J Pathol Microbiol, 56, pp.204~210 (2013)[DOI]
38. Nayak S, "VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas", Oral Oncol, 48, pp.233~239 (2012)[DOI]
39. Desai RS, "Immunohistochemical expression of vascular endothelial growth factor(VEGF)and its possible role in tumour progression during malignant transformation of atrophic epithelium in oral submucous fibrosis", Curr Angiogenes, 1, pp.347~353 (2012)[DOI]
40. Desai RS, "Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis", Oral Oncol, 46, pp.553~558 (2010)[DOI]
41. Pammar C, "Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features : an immunohistochemical study", J Cancer Res Ther, 14, pp.983~988 (2018)[DOI]
42. Sabarinath B, "Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis", Indian J Dent Res, 22, pp.116~121 (2011)[DOI]
43. Sharma E, "Role of angiogenesis in oral submucous fibrosis using vascular endothelial growth factor and CD34 : an immunohistochemical study", Indian J Dent Res, 30, pp.755~762 (2019)[DOI]
44. Sharada P, "Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders", J Oral Maxillofac Pathol, 22, pp.40~47 (2018)[DOI]
45. Kaur A, "Minimal clinically important difference of mouth opening in oral submucous fibrosis patients : a retrospective study", J Korean Assoc Oral Maxillofac Surg, 48, pp.167~173 (2022)[DOI]
46. Qayyum MU, "Nasolabial and extended nasolabial flaps for reconstruction in oral submucous fibrosis", J Korean Assoc Oral Maxillofac Surg, 44, pp.191~197 (2018)[DOI]
47. Bocca C, "Angiogenesis and fibrogenesis in chronic liver diseases", Cell Mol Gastroenterol Hepatol, 1, pp.477~488 (2015)[DOI]
48. Elpek GÖ, "Angiogenesis and liver fibrosis", World J Hepatol, 7, pp.377~391 (2015)[DOI]

관련 논문AI추천